Known targets — ChEMBL curated mechanism
ADORA1ADORA2AADORA2BADORA3PDE3APDE3BPDE4APDE4BPDE4CPDE4D
The experimentally established mechanism targets of Glycine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Glycine SCHEMBL3802015 | 1.00 | GLRA1 (0.71) | — | |
| Glycine SCHEMBL2451754 | 0.89 | — | — | |
| Glycine SCHEMBL13169653 | 0.84 | — | — | |
| Glycine SCHEMBL6675874 | 0.84 | GLRA1 (1.00) | — | |
| Glycine SCHEMBL30179260 | 0.84 | — | — | |
| Glycine SCHEMBL391027 | 0.84 | GLRA1 (1.00) | — | |
| Glycine SCHEMBL2116443 | 0.84 | — | — | |
| Glycine SCHEMBL93765 | 0.84 | GLRA1 (1.00) | — | |
| Glycine SCHEMBL3640989 | 0.84 | GLRA1 (1.00) | — | |
| Glycine SCHEMBL6163 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105000686-B | A kind of salt-soda soil sprinkling irrigation equipment special anti-corrosion antisludging agent and preparation method thereof | 潍坊友容实业有限公司 | 2017-03-29 | — | — | CN | claimed |
| US-20260049039-A1 | MICROFIBRILLATED CELLULOSE AS RHEOLOGY MODIFIER IN HIGH IONIC STRENGTH AGRICULTURAL FORMULATIONS | AMVAC CHEMICAL CORP (US) | 2026-02-19 | — | — | US | disclosed |
| US-12378165-B2 | Pesticide formulation comprising MFC as rheology modifier | AMVAC CHEMICAL CORPORATION (US) | 2025-08-05 | — | — | US | disclosed |
| US-20250128993-A1 | AGRICULTURAL ADJUVANT COMPRISING MICROFIBRILLATED CELLULOSE | AMVAC CHEMICAL CORPORATION | 2025-04-24 | — | — | US | disclosed |
| US-12049431-B2 | Agricultural adjuvant comprising microfibrillated cellulose | AMVAC Chemical Corporation (Subsidiary of American Vanguard Corporation) (US) | 2024-07-30 | — | — | US | disclosed |
| CN-114369328-B | Low-smoke aging-resistant crosslinked elastomer and preparation method thereof | 宁波聚泰新材料科技有限公司 | 2023-12-19 | — | — | CN | disclosed |
| CN-117096406-A | Iron-based negative electrode electrolyte, preparation method thereof and iron-based flow battery | 巨安储能武汉科技有限责任公司 | 2023-11-21 | — | — | CN | disclosed |
| US-20230079931-A1 | MICROFIBRILLATED CELLULOSE AS RHEOLOGY MODIFIER IN HIGH IONIC STRENGTH AGRICULTURAL FORMULATIONS | AMVAC CHEMICAL CORP (US) | 2023-03-16 | — | — | US | disclosed |
| CN-211753892-U | Phyllanine-phosphonic acid synthesis liquid hydrolysis tail gas treatment system | 浙江新安化工集团股份有限公司 | 2020-10-27 | — | — | CN | disclosed |
| CN-211753893-U | System for recovering hydrolysis tail gas of glyphosate-phosphonated synthetic liquid | 浙江新安化工集团股份有限公司 | 2020-10-27 | — | — | CN | disclosed |
| US-7220862-B2 | Calcitonin gene related peptide receptor antagonists | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-05-22 | — | — | US | disclosed |
| EP-1730137-A1 | HETEROCYCLIC CGRP ANTAGONISTS FOR THE TREATMENT OF MIGRAINE | Bristol-Myers Squibb Company (US) | 2006-12-13 | — | — | EP | disclosed |
| EP-1689493-A1 | CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS | Bristol-Myers Squibb Pharma Company (US) | 2006-08-16 | — | — | EP | disclosed |
| WO-2005095383-A1 | HETEROCYCLIC CGRP ANTAGONISTS FOR THE TREATMENT OF MIGRAINE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-10-13 | — | — | WO | disclosed |
| US-20050215576-A1 | Novel therapeutic agents for the treatment of migraine | BRISTOL-MYERS SQUIBB COMPANY | 2005-09-29 | — | — | US | disclosed |
| WO-2005065779-A1 | CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2005-07-21 | — | — | WO | disclosed |
| EP-1539766-A1 | CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS | Bristol-Myers Squibb Company (US) | 2005-06-15 | — | — | EP | disclosed |
| US-20040204397-A1 | Calcitonin gene related peptide receptor antagonists | BRISTOL-MYERS SQUIBB COMPANY | 2004-10-14 | — | — | US | disclosed |
| US-20040063735-A1 | Calcitonin gene related peptide receptor antagonists | BRISTOL-MYERS SQUIBB COMPANY | 2004-04-01 | — | — | US | disclosed |
| WO-2003104236-A1 | CALCITONIN GENE RELATED PEPTIDE RECEPTOR ANTAGONISTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2003-12-18 | — | — | WO | disclosed |